Chart · view recorded under the Health care operations purpose
Withheld from this view and from assistant retrieval:
1 × Reproductive health · 8 × SUD — 42 CFR Part 2.
Sensitive-category records exist and are counted, never silently absent — reaching
them takes the dedicated role and path, and every access is audited as a disclosure.
Your psychotherapy role can open the notes below.
Active problems
| Condition | Status | Onset |
|---|
| Familial Alzheimer's disease of early onset (disorder) |
active |
Aug 26, 2022 |
| History of coronary artery bypass grafting (situation) |
active |
Aug 24, 2012 |
| Abnormal findings diagnostic imaging heart+coronary circulat (finding) |
active |
Aug 15, 2012 |
| Ischemic heart disease (disorder) |
active |
Aug 3, 2012 |
| Neuropathy due to type 2 diabetes mellitus (disorder) |
active |
Jun 30, 2006 |
| Metabolic syndrome X (disorder) |
active |
Jul 18, 2003 |
| Hypertriglyceridemia (disorder) |
active |
Jul 4, 1997 |
| Diabetes mellitus type 2 (disorder) |
active |
Jun 30, 1995 |
| Anemia (disorder) |
active |
Sep 8, 1989 |
| Prediabetes (finding) |
active |
Sep 5, 1986 |
| Risk activity involvement (finding) |
active |
Aug 6, 1971 |
| Epilepsy (disorder) |
active |
Dec 28, 1970 |
| Seizure disorder (disorder) |
active |
Feb 2, 1970 |
| History of seizure (situation) |
active |
Feb 2, 1970 |
Active medications
| Medication | Dosage | Since |
|---|
| 24 HR Donepezil hydrochloride 10 MG / Memantine hydrochloride 28 MG Extended Release Oral Capsule | — |
Sep 20, 2023 |
| 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet | — |
Aug 10, 2012 |
| Clopidogrel 75 MG Oral Tablet | — |
Aug 10, 2012 |
| Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray | — |
Aug 10, 2012 |
| Simvastatin 20 MG Oral Tablet | — |
Aug 10, 2012 |
| clonazePAM 0.25 MG Oral Tablet | — |
Jul 31, 1970 |
Allergies
| Substance | Reaction | Verification |
|---|
| No known allergies recorded. |
Recent results
| Test | Value | When |
|---|
| eGFR |
84.97 mL/min/{1.73_m2} |
Oct 17, 2025 |
| HDL cholesterol |
57.72 mg/dL |
Oct 17, 2025 |
| LDL cholesterol |
118.4 mg/dL |
Oct 17, 2025 |
| Triglycerides |
175.33 mg/dL |
Oct 17, 2025 |
| Total cholesterol |
211.18 mg/dL |
Oct 17, 2025 |
| Potassium |
4.63 mmol/L |
Oct 17, 2025 |
| Sodium |
138.57 mmol/L |
Oct 17, 2025 |
| Glucose |
117.3 mg/dL |
Oct 17, 2025 |
| Respiratory rate |
13 /min |
Oct 17, 2025 |
| Heart rate |
73 /min |
Oct 17, 2025 |
| BMI |
23.78 kg/m2 |
Oct 17, 2025 |
| Body weight |
66.4 kg |
Oct 17, 2025 |
| Pain severity |
3 {score} |
Oct 17, 2025 |
| Body height |
167.1 cm |
Oct 17, 2025 |
| Hemoglobin A1c abnormal |
6.6 % |
Oct 17, 2025 |
| eGFR |
83.01 mL/min/{1.73_m2} |
Jan 10, 2025 |
| HDL cholesterol |
43.05 mg/dL |
Jan 10, 2025 |
| LDL cholesterol |
127.05 mg/dL |
Jan 10, 2025 |
| Triglycerides |
175.83 mg/dL |
Jan 10, 2025 |
| Total cholesterol |
205.26 mg/dL |
Jan 10, 2025 |
| Potassium |
4.23 mmol/L |
Jan 10, 2025 |
| Sodium |
140.07 mmol/L |
Jan 10, 2025 |
| Glucose |
123.49 mg/dL |
Jan 10, 2025 |
| Respiratory rate |
13 /min |
Jan 10, 2025 |
| Heart rate |
96 /min |
Jan 10, 2025 |
| BMI |
23.78 kg/m2 |
Jan 10, 2025 |
| Body weight |
66.4 kg |
Jan 10, 2025 |
| Pain severity |
2 {score} |
Jan 10, 2025 |
| Body height |
167.1 cm |
Jan 10, 2025 |
| Hemoglobin A1c abnormal |
6.6 % |
Jan 10, 2025 |
Notes & documents
| Document | Author | Date | |
|---|
| No unrestricted documents. |
Claims
| Claim | Payer | Date | Status |
Billed | Paid | |
|---|
| CLM-2026172000 | Aetna |
Mar 24, 2026 |
paid |
$516.95 |
$345.12 |
Lines |
| CLM-2026172001 | Aetna |
Mar 10, 2026 |
paid |
$146.18 |
$0.00 |
Lines |
| CLM-2026172002 | Aetna |
Oct 31, 2025 |
paid |
$88.75 |
$2.56 |
Lines |
| CLM-2026172003 | Aetna |
Oct 17, 2025 |
paid |
$724.16 |
$2,454.85 |
Lines |
| CLM-2026172004 | Aetna |
Oct 4, 2025 |
paid |
$516.95 |
$345.12 |
Lines |
| CLM-2026172005 | Aetna |
Aug 1, 2025 |
pending |
$85.57 |
$0.00 |
Lines |
| CLM-2026172007 | Aetna |
Jan 24, 2025 |
paid |
$142.58 |
$0.00 |
Lines |
| CLM-2026172006 | Aetna |
Jan 24, 2025 |
paid |
$85.83 |
$0.22 |
Lines |
